add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
Related: Results 1 - 10 for Lead compoundProsensa receives notice of allowance for key patent related to lead ...PRESS RELEASE Prosensa receives notice of allowance for key patent related to lead compound in development for Duchenne Muscular Dystrophy Leiden, August 17, 2009 - Prosensa, the ... http://www.parentprojectmd.org/site/DocServer/Aug_09_Prosensa_press_release_US_patent.pdf?docID=7821 open pop Incitive's Lead Compound ICV0019 completes Toxicology Studies Microsoft Word - Incitive's Lead Compound ICV0019 completes toxicology studies.doc http://www.incitiveltd.com/downloads/ASX/Incitive%20lead%20compound%20ICV0019%20completes%20toxicology%20studies.pdf open pop Incitive Reports Successful Results for Lead Compound Microsoft Word - Incitive's Lead compound ICV0019 reduces IBD in Animal model v17.doc http://www.incitiveltd.com/downloads/ASX/Incitive%20Lead%20compound%20ICV0019%20reduces%20IBD%20in%20Animal%20model%20%2... open pop Ligand and GlaxoSmithKline Collaboration Identifies New Lead Compound Ligand and GlaxoSmithKline Collaboration Identifies New Lead Compound Ligand Earns Milestone Payment from GlaxoSmithKline SAN DIEGO, Mar 30, 2009 (BUSINESS WIRE) -- Ligand ... http://files.shareholder.com/downloads/LGND/0x0x283361/8ace30bc-4694-42b4-b673-3706c99a8a9d/LGND_News_2009_3_30_General_... open pop Chemokine Therapeutics Corp. (TSX: CTI; OTCBB: CHKT) -Reinitiating ... The first lead drug candidate, CTCE-9908, is an anti -metastases and anti -angiogenic compound that is applicable toawidevarietyof cancers. According to the National Cancer Institute ... http://www.investorideas.com/Research/PDFs/Chem_rein_Aug_2008.pdf open pop PharmEste advances Neuropathic pain therapy to Phase I Clinical Trial ... PharmEste advances Neuropathic pain therapy to Phase I Clinical Trial with its lead compound PHE377. Milan, Italy, July 14, 2009 - PharmEste, a privately held biopharmaceutical ... http://pharmeste.com/include/PHE377.pdf open pop DiaKine Therapeutics' Lead Compound in Phase 2 Clinical Trial 1414 Sachem Place ▪ Suite 3 ▪ Charlottesville, VA 22901 ▪ (434) 9752001 ▪ (434) 9752007Fax ▪ www. diakine. com ###MORE### For Immediate Release Bill Wells - 404 ... http://www.diakine.com/assets/news20081014.pdf open pop PROTEZ PHARMACEUTICALS CLOSES $15 MILLION FINANCING TO PROGRESS LEAD ... PROTEZ PHARMACEUTICALS CLOSES $15 MILLION FINANCING TO PROGRESS LEAD ANTIBIOTIC COMPOUND Unique Broad Spectrum Agent Has Potential Activity Against Multi-Drug Resistant and Other ... http://www.bioadvance.com/news-press-docs/Protez%20Release.pdf open pop DNAPRINT GENOMICS SELECTS PT-502 LEAD RESEARCH COMPOUND FOR ... (more) for immediate release: dnaprint genomics selects pt-502 lead research compound for development of drug for treating depression sarasota, fla., july 17, 2006 -- dnaprint ... http://www.dnaprint.com/welcome/press/press_recent/2006/0717/DNAG-DEPRESSION.pdf open pop BiPar Sciences' Lead Compound Selected as Top 10 Oncology Drug ... BiPar Sciences' Lead Compound Selected as Top 10 Oncology Drug Candidate-- Windhover Chooses BSI-201 as a Top Partnering Candidate --BRISBANE, Calif., October 28, 2008 -- BiPar ... http://www.domainvc.com/PDF/BiPar%20Sciences%20Windhover%20top%2010.pdf open pop | Featured Results:
Compounding Pharmacist ~ Compounding Pharmacy ~ Tennessee Compounding ~... prescriptionspecialties.c... |
| Translate into any language... | ↑ top of page ↑ | about thumbshots |
